Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Lipocine Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +1 vs. Q1 2024
- Shares held
- 531.6K
- +57.7K (+12.2%) vs. Q1 2024
- Total value
- $4.38M
- +$1.92M (+77.7%) vs. Q1 2024
- New holders
- 4
- 6 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 221,459 | $1.82M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 89,272 | $735.6K | 0.00% | +14,750+19.8% | Added |
| UBS Group AG | 56,221 | $463.3K | 0.00% | +55,790+12,944.3% | Added |
| Geode Capital Management, LLC | 53,179 | $438.3K | 0.00% | +4,325+8.9% | Added |
| Renaissance Technologies LLC | 25,697 | $211.7K | 0.00% | +4,600+21.8% | Added |
| Susquehanna International Group, LLP | 25,001 | $206.0K | 0.00% | −34,666−58.1% | Reduced |
| State Street Corp | 18,626 | $153.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 13,160 | $108.4K | 0.00% | +13,160 | New |
| Two Sigma Advisers, LP | 12,822 | $105.7K | 0.00% | −12,900−50.2% | Reduced |
| Dimensional Fund Advisors LP | 11,870 | $97.8K | 0.00% | +11,870 | New |
| Morgan Stanley | 2,634 | $21.7K | 0.00% | +1,912+264.8% | Added |
| Tower Research Capital LLC (TRC) | 772 | $6.36K | 0.00% | −1,242−61.7% | Reduced |
| Caldwell Sutter Capital, Inc. | 471 | $3.88K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 227 | $1.87K | 0.00% | +159+233.8% | Added |
| Clearstead Advisors, LLC | 74 | $610 | 0.00% | +74 | New |
| Tidemark, LLC | 59 | $486 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 44 | $363 | 0.00% | +44 | New |
| Group One Trading, L.P. | 16 | $132 | 0.00% | −24−60.0% | Reduced |
| Royal Bank of Canada | 9 | $0 | 0.00% | −5−35.7% | Reduced |
| Old Point Trust & Financial Services N A | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −12−100.0% | Sold out |